Once the dossier is in, the developer role in a joint clinical assessment narrows sharply. Knowing the few points where you can act, and the many where you cannot, is essential to resourcing a JCA team.
The assessment phase
Assessors from the Member State Coordination Group assess the dossier, review the literature search and appraise bias and certainty. Under Implementing Regulation (EU) 2024/1381, the developer has no upfront opportunity for input at this stage, and additional information can be provided only when the Coordination Group asks for it. Questions can arrive on short timelines, so a standing response team matters.
The one formal chance to comment
The developer may review the draft report and flag technical or factual inaccuracies and confidential information. The review period is seven days, reducible to five in some circumstances. The regulation does not define technical or factual inaccuracies, so the boundary between a correction and a disagreement is untested.
- Keep a verified data pack, with source tables, ready to cite.
- Pre-agree who reviews confidentiality claims and how they are evidenced.
- Prepare for a very short turnaround, including internal sign-off.
What the report is, and is not
The JCA report is a scientific assessment. It does not contain a value judgement on added clinical benefit, and it does not decide pricing or reimbursement. National bodies must consider the published reports in their own assessments, so the report becomes a reference point in Greek and other national procedures without replacing them.
Practical implications
- Treat the dossier as the main instrument: gaps cannot be fixed at the draft stage.
- Align the JCA dossier with national dossiers so numbers and analyses are consistent across submissions.
- Plan how the published report will be used in Greek HTA, pricing and negotiation discussions.
How PQRA helps
PQRA helps teams prepare JCA dossiers, set up rapid-response processes for assessor questions and draft report review, and translate JCA outputs into Greek HTA and reimbursement strategy.
Building a JCA response process? Contact PQRA for a practical discussion.


No responses yet